Concepts (75)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2017 | 449 | 0.52 | Why? |
| Immunoassay | 3 | 2021 | 4485 | 0.41 | Why? |
| Microbial Sensitivity Tests | 2 | 2017 | 2886 | 0.37 | Why? |
| Immunoglobulin M | 3 | 2021 | 9091 | 0.37 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.36 | Why? |
| Antibodies, Viral | 8 | 2021 | 51949 | 0.36 | Why? |
| Point-of-Care Testing | 1 | 2021 | 2782 | 0.35 | Why? |
| Antibody Formation | 1 | 2021 | 4038 | 0.34 | Why? |
| Bacteria | 1 | 2017 | 1897 | 0.31 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.30 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.28 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2021 | 11367 | 0.28 | Why? |
| Immunoglobulin G | 3 | 2021 | 21571 | 0.23 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.21 | Why? |
| Luminescence | 1 | 2020 | 236 | 0.20 | Why? |
| Sensitivity and Specificity | 4 | 2021 | 22971 | 0.20 | Why? |
| Luminescent Measurements | 2 | 2020 | 924 | 0.18 | Why? |
| Lyme Disease | 1 | 2019 | 102 | 0.17 | Why? |
| Anti-Bacterial Agents | 2 | 2017 | 10083 | 0.17 | Why? |
| Liquid Biopsy | 1 | 2017 | 114 | 0.16 | Why? |
| RNA, Messenger | 2 | 2021 | 5131 | 0.16 | Why? |
| Belgium | 2 | 2020 | 2064 | 0.16 | Why? |
| Immunogenicity, Vaccine | 2 | 2021 | 4624 | 0.15 | Why? |
| Genes, Viral | 1 | 2021 | 1428 | 0.14 | Why? |
| Bacteriological Techniques | 1 | 2017 | 239 | 0.14 | Why? |
| Hospitals, Public | 1 | 2020 | 774 | 0.13 | Why? |
| Infertility | 1 | 2017 | 247 | 0.13 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.13 | Why? |
| False Negative Reactions | 1 | 2020 | 1785 | 0.13 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.13 | Why? |
| Limit of Detection | 1 | 2020 | 2698 | 0.12 | Why? |
| Kinetics | 1 | 2020 | 3238 | 0.11 | Why? |
| Cholic Acid | 1 | 2010 | 2 | 0.11 | Why? |
| Tobramycin | 1 | 2010 | 18 | 0.11 | Why? |
| Health Personnel | 4 | 2021 | 29646 | 0.11 | Why? |
| Phosphoproteins | 1 | 2021 | 4346 | 0.10 | Why? |
| Humans | 16 | 2021 | 930598 | 0.09 | Why? |
| Biofilms | 1 | 2010 | 304 | 0.08 | Why? |
| Survival Analysis | 1 | 2020 | 7592 | 0.08 | Why? |
| Microbial Viability | 1 | 2010 | 406 | 0.08 | Why? |
| Pseudomonas aeruginosa | 1 | 2010 | 652 | 0.07 | Why? |
| Europe | 1 | 2021 | 12702 | 0.07 | Why? |
| Antigens, Viral | 1 | 2021 | 6298 | 0.07 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.06 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.06 | Why? |
| RNA, Viral | 2 | 2021 | 32276 | 0.06 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.06 | Why? |
| Disease Outbreaks | 2 | 2021 | 27595 | 0.06 | Why? |
| Population Surveillance | 1 | 2019 | 4967 | 0.06 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.06 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.05 | Why? |
| Mutation | 1 | 2021 | 12376 | 0.05 | Why? |
| Retrospective Studies | 3 | 2020 | 105322 | 0.05 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.05 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.05 | Why? |
| Borrelia burgdorferi | 1 | 2019 | 31 | 0.05 | Why? |
| Tick Bites | 1 | 2019 | 34 | 0.05 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
| Area Under Curve | 1 | 2020 | 2564 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.03 | Why? |
| Cell Membrane Permeability | 1 | 2010 | 84 | 0.03 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.02 | Why? |
| Reagent Kits, Diagnostic | 1 | 2020 | 2149 | 0.02 | Why? |
| ROC Curve | 1 | 2020 | 6024 | 0.02 | Why? |
| Adult | 3 | 2020 | 244371 | 0.02 | Why? |
| Middle Aged | 3 | 2020 | 270681 | 0.02 | Why? |
| Male | 3 | 2020 | 367725 | 0.02 | Why? |
| Female | 3 | 2020 | 380317 | 0.02 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.02 | Why? |
| Aged | 1 | 2020 | 215776 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2019 | 10017 | 0.02 | Why? |
| Drug Interactions | 1 | 2010 | 1653 | 0.02 | Why? |
| Endothelial Cells | 1 | 2010 | 2048 | 0.01 | Why? |
| Risk Factors | 1 | 2019 | 71621 | 0.01 | Why? |
| Young Adult | 1 | 2019 | 93724 | 0.01 | Why? |